Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results

BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cen, Putao, Tetzlaff, Eric D, Ajani, Jaffer A
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2008
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2503649/
https://ncbi.nlm.nih.gov/pubmed/18728703
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki